Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Odborné odporúčania na liečbu rakoviny prsníka založené na najnovších dôkazoch budú aktualizované vo viacerých jazykoch
  • USA - Deutsch
  • USA - español
  • USA - čeština
  • USA - Polski
  • USA - Français
  • Brazil - Português
  • USA - Pусский
  • USA - English
  • Latin America - español

NCCN Logo (C)NCCN(R) 2018. All rights reserved.

News provided by

National Comprehensive Cancer Network

Oct 05, 2020, 05:13 ET

Share this article

Share toX

Share this article

Share toX

Prebiehajú priebežné aktualizácie pokynov NCCN pre rakovinu prsníka v čínštine, angličtine, francúzštine, japončine, kórejčine, španielčine, poľštine a portugalčine, ktoré sú zadarmo online na stránke NCCN.org/global. Ak chcete získať viac informácií, sledujte #NCCNGlobal.

Nadácia NCCN organizuje 8. a 12. októbra bezplatné webináre o metastatickom karcinóme prsníka pre pacientov a ošetrovateľov na adrese NCCN.org/patients.

PLYMOUTH MEETING, Pensylvánia, 5. októbra 2020 /PRNewswire/ -- Počas mesiaca povedomia o rakovine prsníka, ktorý prebieha tento október, Národná komplexná sieť pre rakovinu® (National Comprehensive Cancer Network® (NCCN®) zdieľa a aktualizuje dôkazy a odporúčania založené na konsenze odborníkov, ktoré vedú k optimálnym výsledkom pre ľudí s rakovinou prsníka.1 Preklady anglických Pokynov od NCCN® pre rakovinu prsníka boli nedávno aktualizované do čínštiny, japončiny a španielčiny. Momentálne dostupná kórejská, francúzska, poľská a portugalská verzia bude aktualizovaná do konca mesiaca. Všetky sú zadarmo na NCCN.org/global.

Continue Reading
NCCN Guidelines® for Breast Cancer in Chinese, French, Japanese, Korean, Polish, Portuguese, and Spanish.
NCCN Guidelines® for Breast Cancer in Chinese, French, Japanese, Korean, Polish, Portuguese, and Spanish.

„Rakovina prsníka má veľmi vysokú mieru vyliečenia, ale zostáva najčastejšou rakovinou a najčastejšou príčinou úmrtí žien na rakovinu na celom svete," uviedol Robert W. Carlson, MD, výkonný riaditeľ NCCN a emeritný profesor medicíny na Stanford University Medical Center, ktorý sa špecializuje na rakovinu prsníka. „Chceme, aby poskytovatelia zdravotnej starostlivosti mali prístup k starostlivo prevereným liečebným odporúčaniam zahrnutým v pokynoch NCCN. Preto vždy hľadáme spôsoby, ako zvýšiť čitateľnosť a dostupnosť týchto zdrojov."

NCCN tiež prispôsobuje pokyny NCCN odstupňovaným a pragmatickým prístupom kvôli rôznym dostupnostiam zdrojov v krajinách s nízkym a stredným príjmom, ktoré sa nazývajú Rámec NCCN pre stratifikáciu pokynov NCCN (NCCN Framework™). Existujú aj medzinárodné prispôsobenia pokynov NCCN pre rakovinu prsníka pre región Blízkeho východu a severnej Afriky (MENA) a Španielska, ako aj harmonizované pokyny NCCN TM pre subsaharskú Afriku a Karibik, všetky vypracované v spolupráci s regionálnymi odborníkmi na onkológiu. 

Pokyny NCCN pre rakovinu prsníka slúžili aj ako základ pre vytvorenie troch zväzkov Pokynov NCCN pre pacientov®, ktoré majú pacientom s rakovinou pomôcť hovoriť so svojimi lekármi o najlepších možnostiach liečby duktálneho karcinómu in situ (DCIS), invazívneho karcinómu prsníka, a metastatického karcinómu prsníka.

„Rozširujeme naše vedomosti o tomto ochorení rýchlym tempom," uviedol William J. Gradishar, MD, Komplexné centrum pre rakovinu Roberta H. Lurieho, Northwestern University, predseda panelu pre pokyny NCCN pre rakovinu prsníka. "Už tento rok sme vykonali šesť aktualizácií hlavných pokynov pre rakovinu prsníka. Zahŕňajú niekoľko nových liečebných odporúčaní týkajúcich sa manažmentu, štádií a zvláštnych okolností, ako je tehotenstvo."

NCCN má tiež samostatné pokyny týkajúce sa tém, ako je skríning, genetické/rodinné hodnotenie rizika, znižovanie rizika a podporná starostlivosť.

Pokyny NCCN pre rakovinu prsníka boli v roku 2019 stiahnuté viac ako 890 000-krát, čo z nich robí najsťahovanejšie pokyny NCCN zo všetkých typov rakoviny. Najmenej 335 000 týchto stiahnutí pochádzalo zo štátov mimo USA, z toho viac ako 36 000 zo Španielska a Mexika, 31 000 z Číny a 21 000 z Brazílie. Neanglické verzie boli stiahnuté viac ako 4 000-krát.

Navštívte NCCN.org/global, kde sa dozviete viac o všetkých dostupných zdrojoch týkajúcich sa rakoviny, a zapojte sa do konverzácie s hashtagom #NCCNGlobal.

Webinár pre pacientov s rakovinou prsníka zdarma
Nadácia NCCN® organizuje 8. a 12. októbra 2020 dva bezplatné webináre pre pacientov o metastatickom karcinóme prsníka, ktoré sú založené na Pokynoch NCCN pre pacientov.

Navštívte stránku nccn.org/patients/reZdrojs/breast-cancer-2020.aspx pre viac informácií a registráciu.

O národnej onkologickej sieti National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) je nezisková aliancia popredných onkologických centier, ktoré sa venujú starostlivosti o pacientov, výskumu a vzdelávaniu. NCCN sa usiluje o zlepšovanie a zabezpečenie kvality, efektívnosti a účinnosti liečby rakoviny, aby pacienti mohli žiť lepší život. Odporúčané postupy pre klinickú prax v onkológii NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) poskytujú transparentné dôkazy, podporené a odborníkmi odsúhlasené odporúčania pre liečbu a prevenciu rakoviny, vrátane podporných služieb. Tieto odporúčania sú považované za uznávaný štandard klinickej starostlivosti a politikou pre liečbu rakoviny. Ide o najobsiahlejšie a najčastejšie aktualizované pokyny zo všetkých odvetví medicíny. Pokyny pre pacientov NCCN Guidelines for Patients® prinášajú odborné informácie o liečbe rakoviny pre pacientov a ošetrujúce osoby, a to vďaka podpore nadácie NCCN Foundation®. NCCN tiež podporuje sústavné vzdelávanie, globálne iniciatívy, politiku, a spoluprácu v oblasti výskumu a publikovanie v onkológii. Ďalšie informácie nájdete na stránkach NCCN.org alebo môžete NCCN sledovať na sociálnych sieťach Facebook @NCCNorg, Instagrame @NCCNorg a Twitteri @NCCN.




1 Vaddepally. J Clin Oncol 36, suppl 30; abstr 47, 2018, https://meetinglibrary.asco.org/record/166668/abstract.

Media Contact:
Rachel Darwin
267-622-6624
[email protected] 

Fotografia - https://mma.prnewswire.com/media/1306011/NCCN_Breast_Cancer_Guidelines_Translations.jpg

Logo - https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg

Related Links

www.nccn.org

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Human Approach is Hypothesized to be Superior to Technology for Supportive Cancer Care According to New Data in JNCCN

Human Approach is Hypothesized to be Superior to Technology for Supportive Cancer Care According to New Data in JNCCN

New research in the November 2025 issue of JNCCN—Journal of the National Comprehensive Cancer Network explores the perceptions regarding the...

NCCN Celebrates Expanding Access to Cancer Treatment in Africa at 2025 AORTIC Meeting with New NCCN Adaptations for Sub-Saharan Africa

NCCN Celebrates Expanding Access to Cancer Treatment in Africa at 2025 AORTIC Meeting with New NCCN Adaptations for Sub-Saharan Africa

The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—collaborated with the African Cancer...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Public Safety

Public Safety

Not For Profit

Not For Profit

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.